brand logo

Am Fam Physician. 2012;86(9):online

Clinical Question: Does intensive glucose control in patients with type 2 diabetes improve outcomes more than usual control?

Bottom Line: This study confirms the initial findings of the ACCORD study: In middle-aged or older patients with cardiovascular risk factors, the best target for glycated hemoglobin is between 7.0% and 7.9%. (Level of Evidence: 1b)

Reference: The ACCORD study group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364(9):818-828.

Study Design: Randomized controlled trial (double-blinded)

Funding Source: Government

Allocation: Concealed

Setting: Outpatient (any)

Synopsis: The ACCORD study randomized persons aged 40 to 79 years with type 2 diabetes mellitus and known cardiovascular disease or cardiovascular risk factors to either intensive glucose control (glycated hemoglobin target < 6.0%) or usual control (7.0% to 7.9%). The study was stopped after 3.7 years when a significant increase in all-cause mortality was detected in the intensive therapy group. At that time, the median glycated hemoglobin levels were 6.4% and 7.5% in the intensive and usual treatment groups, respectively. At that time, the target for patients in the intensive therapy group was relaxed to a target glycated hemoglobin between 7.0% and 7.9%; follow-up continued for an additional 17 months. This report describes the results at the end of the entire 5 year follow-up period. At that time, the median glycated hemoglobin levels were 7.2% and 7.6%. Essentially, there was little difference between the outcomes of the original study and those at 5 years. Although nonfatal myocardial infarctions were still less common after 5 years (hazard ratio [HR] = 0.82; 95% CI, 0.7 - 0.96), cardiovascular and all-cause deaths (HR = 1.19; 1.03 - 1.38) were more common.

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at

Continue Reading

More in AFP

Copyright © 2012 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.